TRxADE HEALTH, Inc. (MEDS)
NASDAQ: MEDS · IEX Real-Time Price · USD
1.26
0.02 (1.61%)
At close: May 16, 2022 3:59 PM
1.27
0.01 (0.79%)
After-hours:May 16, 2022 4:00 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.89 | 17.12 | 7.44 | 3.83 | 2.93 | 2.48 | 2.91 | 1.5 | 0.96 |
| Revenue Growth (YoY) | -42.24% | 130.26% | 94.07% | 30.72% | 18.11% | -14.79% | 94.66% | 56.53% | - |
| Cost of Revenue | 5.14 | 11.42 | 2.57 | 0.45 | 0 | 0 | 0.19 | 0.44 | 0.94 |
| Gross Profit | 4.75 | 5.71 | 4.87 | 3.38 | 2.93 | 2.48 | 2.72 | 1.06 | 0.01 |
| Selling, General & Admin | 8.81 | 7.49 | 4.38 | 3.47 | 2.54 | 3.49 | 2.86 | 2.49 | 2.1 |
| Other Operating Expenses | 1.23 | 0.73 | 0.37 | 0 | -0.07 | -0.02 | 0 | 0 | 0 |
| Operating Expenses | 10.04 | 8.21 | 4.75 | 3.47 | 2.47 | 3.47 | 2.86 | 2.49 | 2.1 |
| Operating Income | -5.29 | -2.51 | 0.13 | -0.09 | 0.46 | -0.98 | -0.14 | -1.43 | -2.08 |
| Interest Expense / Income | 0.02 | 0.03 | 0.05 | 0.06 | 0.16 | 0.15 | 0.12 | 0 | 0.01 |
| Other Expense / Income | 0 | 0 | 0.36 | -0.15 | 0.02 | 1.62 | 0.86 | 0.58 | 0 |
| Pretax Income | -5.32 | -2.54 | -0.28 | 0.01 | 0.29 | -2.76 | -1.12 | -2.01 | -2.09 |
| Net Income | -5.32 | -2.54 | -0.28 | 0.01 | 0.29 | -2.76 | -1.12 | -2.01 | -2.09 |
| Net Income Common | -5.32 | -2.54 | -0.28 | 0.01 | 0.29 | -2.76 | -1.12 | -2.01 | -2.09 |
| Net Income Growth | - | - | - | -96.87% | - | - | - | - | - |
| Shares Outstanding (Basic) | 8 | 8 | 6 | 5 | 5 | 5 | 5 | 5 | 2 |
| Shares Outstanding (Diluted) | 8 | 8 | 6 | 6 | 6 | 5 | 5 | 5 | 2 |
| Shares Change | 5.59% | 29.96% | 1.76% | 2.56% | 8.06% | 0.73% | 4.98% | 111.54% | - |
| EPS (Basic) | -0.65 | -0.33 | -0.05 | - | 0.06 | -0.54 | -0.24 | -0.42 | -0.90 |
| EPS (Diluted) | -0.65 | -0.33 | -0.05 | - | 0.06 | -0.54 | -0.24 | -0.42 | -0.90 |
| Free Cash Flow Per Share | -0.32 | -0.29 | 0.01 | 0.05 | 0.03 | -0.10 | 0.02 | -0.21 | -0.35 |
| Gross Margin | 47.99% | 33.33% | 65.50% | 88.28% | 100.00% | 100.00% | 93.48% | 70.59% | 1.24% |
| Operating Margin | -53.51% | -14.64% | 1.68% | -2.29% | 15.78% | -39.65% | -4.71% | -95.67% | -218.02% |
| Profit Margin | -53.75% | -14.81% | -3.82% | 0.24% | 9.86% | -111.21% | -38.36% | -134.47% | -218.78% |
| Free Cash Flow Margin | -26.18% | -13.15% | 0.80% | 6.74% | 5.86% | -20.29% | 3.10% | -71.15% | -87.21% |
| EBITDA | -5.15 | -2.4 | -0.14 | 0.07 | 0.45 | -2.61 | -0.99 | -2 | -2.08 |
| EBITDA Margin | -52.11% | -14.04% | -1.84% | 1.74% | 15.22% | -105.11% | -34.12% | -133.88% | -217.60% |
| EBIT | -5.29 | -2.51 | -0.23 | 0.07 | 0.45 | -2.61 | -1 | -2.01 | -2.08 |
| EBIT Margin | -53.51% | -14.64% | -3.11% | 1.74% | 15.22% | -105.11% | -34.25% | -134.20% | -218.02% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).